Reference Safety Information – update from the Clinical Trials Facilition Group

03 October 2013

The Clinical Trial Facilitation Group (CTFG) has drawn up a document on Reference Safety Information (RSI). It describes the requirements for the RSI when submitting an application for a new trial, but also what to do in ongoing trials.

The CTFG was formed in 2004 by the Heads of Medicines Agencies (HMA), one of the purposes being to obtain a more uniform interpretation of the EU regulatory requirements.

Reference Safety Information (RSI) for a Clinical Trial

Did you get answers to your questions?

Please tell us how we can improve our website?